share_log

Allarity Therapeutics Announces Board Appoints James G. Cullem, J.D., To Interim CEO And Joan Y. Brown, CPA, To Interim CFO

Benzinga Real-time News ·  Jun 30, 2022 04:05
Allarity Therapeutics Announces Board Appoints James G. Cullem, J.D., To Interim CEO And Joan Y. Brown, CPA, To Interim CFO
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment